PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,347,361 | -22.6% | 565,429 | +1.1% | 4.35% | -6.7% |
| Q2 2023 | $22,407,504 | -2.3% | 559,209 | -0.4% | 4.66% | -3.3% |
| Q1 2023 | $22,923,385 | +5.4% | 561,710 | -0.3% | 4.82% | +0.3% |
| Q4 2022 | $21,753,453 | -28.8% | 563,415 | -1.9% | 4.80% | -28.5% |
| Q3 2022 | $30,563,000 | -11.8% | 574,608 | -3.3% | 6.72% | -7.5% |
| Q2 2022 | $34,653,000 | -25.7% | 594,392 | -2.7% | 7.26% | -4.5% |
| Q1 2022 | $46,626,000 | +26.2% | 610,933 | -0.5% | 7.60% | +37.3% |
| Q4 2021 | $36,932,000 | +15.6% | 613,790 | +7.6% | 5.54% | +16.7% |
| Q3 2021 | $31,956,000 | +5.5% | 570,643 | +14.3% | 4.75% | +10.4% |
| Q2 2021 | $30,300,000 | -5.0% | 499,333 | +9.8% | 4.30% | -11.4% |
| Q1 2021 | $31,880,000 | +22.5% | 454,849 | +4.6% | 4.86% | +17.2% |
| Q4 2020 | $26,028,000 | +1.7% | 434,955 | +2.2% | 4.14% | -24.1% |
| Q3 2020 | $25,591,000 | +15.5% | 425,667 | +0.8% | 5.46% | +1.7% |
| Q2 2020 | $22,150,000 | +62.2% | 422,141 | +3.7% | 5.36% | +15.7% |
| Q1 2020 | $13,652,000 | -21.9% | 407,159 | +5.5% | 4.64% | +21.2% |
| Q4 2019 | $17,482,000 | +18.5% | 385,912 | -0.4% | 3.83% | +9.6% |
| Q3 2019 | $14,748,000 | +21.7% | 387,379 | +39.0% | 3.49% | +33.6% |
| Q2 2019 | $12,117,000 | – | 278,613 | – | 2.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |